Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabotropic Glutamate Receptors for Parkinson's Disease Therapy
F. Gasparini, Thérèse Di Paolo, Baltazar Gomez‐Mancilla
Parkinson s Disease (2013) Vol. 2013, pp. 1-11
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Matthieu F. Bastide, Wassilios G. Meissner, Barbara Picconi, et al.
Progress in Neurobiology (2015) Vol. 132, pp. 96-168
Open Access | Times Cited: 430
A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease
Giulia Ambrosi, Silvia Cerri, Fabio Blandini
Journal of Neural Transmission (2013) Vol. 121, Iss. 8, pp. 849-859
Closed Access | Times Cited: 182
Computational Models Describing Possible Mechanisms for Generation of Excessive Beta Oscillations in Parkinson’s Disease
Alex Pavlides, S. J. Hogan, Rafał Bogacz
PLoS Computational Biology (2015) Vol. 11, Iss. 12, pp. e1004609-e1004609
Open Access | Times Cited: 162
Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis
Medi Kori, Büşra Aydın, Semra Ünal, et al.
OMICS A Journal of Integrative Biology (2016) Vol. 20, Iss. 11, pp. 645-661
Closed Access | Times Cited: 128
Type-B monoamine oxidase inhibitors in neurological diseases
Marika Alborghetti, Edoardo Bianchini, Lanfranco De Carolis, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 1, pp. 16-21
Open Access | Times Cited: 28
Management of Parkinson׳s disease: Current and future pharmacotherapy
Ashish Kumar Kakkar, Neha Dahiya
European Journal of Pharmacology (2015) Vol. 750, pp. 74-81
Closed Access | Times Cited: 84
Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research
Nadhir Litim, Marc Morissette, Thérèse Di Paolo
Neuropharmacology (2016) Vol. 115, pp. 166-179
Closed Access | Times Cited: 78
IGF-1 Alleviates NMDA-Induced Excitotoxicity in Cultured Hippocampal Neurons Against Autophagy via the NR2B/PI3K-AKT-mTOR Pathway
Yansong Wang, Wei Wang, Dongguo Li, et al.
Journal of Cellular Physiology (2014) Vol. 229, Iss. 11, pp. 1618-1629
Closed Access | Times Cited: 74
Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias
Tanuja Bordia, Xiomara A. Perez, Jaime E. Heiss, et al.
Neurobiology of Disease (2016) Vol. 91, pp. 47-58
Open Access | Times Cited: 74
The impact of metabotropic glutamate receptors into active neurodegenerative processes: A “dark side” in the development of new symptomatic treatments for neurologic and psychiatric disorders
Valeria Bruno, Filippo Caraci, Agata Copani, et al.
Neuropharmacology (2016) Vol. 115, pp. 180-192
Closed Access | Times Cited: 67
Neurotoxic Agent-Induced Injury in Neurodegenerative Disease Model: Focus on Involvement of Glutamate Receptors
Md. Jakaria, Shin‐Young Park, Md. Ezazul Haque, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 62
The multi‐faceted role of mitochondria in the pathology of Parkinson’s disease
Dennison Trinh, Ahmad R. Israwi, Lindsay R. Arathoon, et al.
Journal of Neurochemistry (2020) Vol. 156, Iss. 6, pp. 715-752
Open Access | Times Cited: 61
Nicotine and Nicotinic Receptor Drugs
Maryka Quik, Tanuja Bordia, Danhui Zhang, et al.
International review of neurobiology (2015), pp. 247-271
Closed Access | Times Cited: 63
Location-Dependent Signaling of the Group 1 Metabotropic Glutamate Receptor mGlu5
Yuh-Jiin I. Jong, Ismail Sergin, Carolyn A. Purgert, et al.
Molecular Pharmacology (2014) Vol. 86, Iss. 6, pp. 774-785
Open Access | Times Cited: 58
Role for the nicotinic cholinergic system in movement disorders; therapeutic implications
Maryka Quik, Danhui Zhang, Xiomara A. Perez, et al.
Pharmacology & Therapeutics (2014) Vol. 144, Iss. 1, pp. 50-59
Open Access | Times Cited: 56
Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease
Marianne Amalric
Current Opinion in Pharmacology (2014) Vol. 20, pp. 29-34
Closed Access | Times Cited: 53
Development of PET and SPECT Probes for Glutamate Receptors
Takeshi Fuchigami, Morio Nakayama, Sakura Yoshida
The Scientific World JOURNAL (2015) Vol. 2015, Iss. 1
Open Access | Times Cited: 51
Protective effects of functional foods against Parkinson's disease: A narrative review on pharmacology, phytochemistry, and molecular mechanisms
Milad Iranshahy, Behjat Javadi, Amirhossein Sahebkar
Phytotherapy Research (2022) Vol. 36, Iss. 5, pp. 1952-1989
Closed Access | Times Cited: 25
Inhibition of group-I metabotropic glutamate receptors protects against prion toxicity
Despoina Goniotaki, Asvin KK Lakkaraju, Amulya Nidhi Shrivastava, et al.
PLoS Pathogens (2017) Vol. 13, Iss. 11, pp. e1006733-e1006733
Open Access | Times Cited: 46
18F‐FPEB PET/CT Shows mGluR5 Upregulation in Parkinson's Disease
Yeona Kang, Claire Henchcliffe, Ajay Verma, et al.
Journal of Neuroimaging (2018) Vol. 29, Iss. 1, pp. 97-103
Open Access | Times Cited: 34
Blockade of metabotropic glutamate receptor 5 protects against DNA damage in a rotenone-induced Parkinson's disease model
Ning Xia, Qian Zhang, Shu Ting Wang, et al.
Free Radical Biology and Medicine (2015) Vol. 89, pp. 567-580
Closed Access | Times Cited: 33
Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical Correlates
Nicolas Morin, Thérèse Di Paolo
Frontiers in Neurology (2014) Vol. 5
Open Access | Times Cited: 33
Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy
Mariana Babayeva, Haregewein Assefa, Paramita Basu, et al.
Parkinson s Disease (2016) Vol. 2016, pp. 1-19
Open Access | Times Cited: 27
Selective blockade of mGlu5 metabotropic glutamate receptors is protective against hepatic mitochondrial dysfunction in 6‐OHDA lesioned Parkinsonian rats
Andrea Ferrigno, Mariapia Vairetti, Giulia Ambrosi, et al.
Clinical and Experimental Pharmacology and Physiology (2015) Vol. 42, Iss. 6, pp. 695-703
Closed Access | Times Cited: 25
α7 nicotinic receptor agonists reduce levodopa‐induced dyskinesias with severe nigrostriatal damage
Danhui Zhang, Matthew McGregor, Tanuja Bordia, et al.
Movement Disorders (2015) Vol. 30, Iss. 14, pp. 1901-1911
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top